PEOPLE - Changes at Banyan Biomarkers:
This article was originally published in Clinica
Executive Summary
Ronald Hayes and Kevin Wang, two of the three founders of Banyan Biomarkers (Gainesville, Florida), have joined the firm on a full time basis. The company is developing point-of-care tests to diagnose brain injury. As director of innovative research and clinical programmes, Dr Hayes will manage clinical developments. Dr Wang is named as chief scientific officer and associate director of the research and clinical programmes. Both executives have been widely published, and both previously held senior executive and professorial positions at the University of Florida's traumatic brain injury studies centre.
You may also be interested in...
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.